NIH-funded research R01 grant

Secondary cervical cancer prevention for women with HIV in India

Official title: Secondary Cervical Cancer Prevention of Vulnerable Women with HPV and HIV Co-infection in India

Funded at University of California-Irvine · NIH-11535289 · Data updated 2026-11-12

This project tests a nurse-led, peer-supported program to help women with HIV who are at risk for cervical cancer through HPV screening, nutrition, and emotional support in rural India.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of California-Irvine
NIH-funded
Lab location1 site (Irvine, United States)
Project startAugust 1, 2023
Project endJuly 31, 2029
Funding year2026
Award (this year)$26,388
NIH project number3R01CA285063-04S1
Project IDNIH-11535289 on NIH RePORTER

Who could benefit from this research

Could help

Women living with HIV/AIDS in rural India who have limited access to HPV screening and nutritional/psychosocial support.

Less likely to help

Individuals without HIV or those with good access to HPV screening and nutrition programs may see little or no direct benefit.

What this research studies

Women living with HIV in India often face higher risk of cervical cancer and barriers to screening. The study builds on a prior program that combined nurse leadership with peer counselors to provide emotional support, nutrition education, and protein supplements, aiming to improve immune health and reduce precancerous cervical lesions. Participants receive integrated care that includes HPV screening, psychosocial support, and dietary interventions, with follow-up to track cervical health and immune markers. The research seeks to show whether this holistic approach can lower cancer risk and improve well-being for WLH with limited access to health services.

Why it matters

Potential benefit: If successful, the program could reduce cervical cancer risk and improve overall health and quality of life for women living with HIV in low-resource settings.

How similar studies have gone: Previous work showed improvements in immune markers, nutrition, and depression, with a signal toward reduced cervical lesion risk, warranting further study.

Where this research is happening

  • University of California-Irvine
    Irvine, United States
    Active

Researchers

  • Principal investigator: Nyamathi, Adeline M — University of California-Irvine
  • Study coordinator: Nyamathi, Adeline M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.